Study on the development of therapy for insulin-dependent diabetes melitus addressing the regulation of pancreatic beta-cells death.

研究胰岛素依赖型糖尿病疗法的发展，解决胰腺β细胞死亡的调节问题。

• 批准号: 07557354
• 负责人: KONDO Takahito
• 金额: $ 5.44万
• 依托单位: Nagasaki University
• 依托单位国家: 日本
• 项目类别: Grant-in-Aid for Scientific Research (A)
• 财政年份: 1995
• 资助国家: 日本
• 起止时间: 1995 至 1997
• 项目状态: 已结题
• 来源: https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-07557354/
• 关键词: gamma-glutamylcysteine; glutathione; ribozyme; IDDM; beta-Cell; redox; NF-_kB; TNF-alpha; NF-κB; マウスβ細胞; β-GCS; サイトカイン

Development of gene therapy for IDDM addressing regration of pancreatic beta-cell death. We used mouse pancreatic beta-cell lines, Min-6 and beta-TC as materials. We estimated antioxidant activities, insulin secretion, expression of preproinsulin gene, and analyzed the preproinsulin gene promoter. beta-cell damage was estimated as DNA damage induced by the treatment of these cells with TNF-alpha and IL- 1beta. To regulate the antioxidant activity and redox, we cloned the gene of gamma-glutamylcysteine synthetase (gamma-GCS), the rate-limiting enzyme for the glutathione (GSH) synthesis, and analyzed the 5'-flanking region of gamma-GCS gene. To suppress the expression of gamma-GCS,beta-cells were transfected with antisense codon of gamma-GCS constructed with ribozyme.Results1. Levels of GSH and activities of GSH related enzymes decreased by 90% in Min-6 and beta-TC cells compared to other mouse tissues cells, suggesting beta-cells are feasible to oxidative stress and possess less redox activity.2. The insulin secretion was down-regulated by GSH.3. The expression of preproinsulin was not regulated by GSH.4. GSH protected beta-cell damage by cytokines.5. Transfection of anti-gamma-GCS-ribozyme caused of increase in insulin-secretion.6. These data suggest low concentration of GSH in beta-cells is essential for the insulin secretion while sensitive to cellular damage by oxidants.Collectively, new gene therapy targeting the suppression of GSH synthesis thought to be effective to IDDM.

针对胰岛β细胞死亡调节的IDDM基因治疗进展。以小鼠胰岛β细胞系Min-6和β-TC为材料。测定抗氧化活性、胰岛素分泌、胰岛素原基因表达，并对胰岛素原基因启动子进行分析。β细胞损伤是指用肿瘤坏死因子-α和白介素1-β处理这些细胞所引起的DNA损伤。为了调节抗氧化活性和氧化还原，我们克隆了谷胱甘肽(GSH)合成的限速酶--γ-谷氨酰半胱氨酸合成酶(GCS)基因，并对其5‘侧翼区进行了分析。为抑制γ-GCS的表达，将核酶构建的伽马-GCS反义密码子导入β细胞。与其他小鼠组织细胞相比，Min-6和β-TC细胞的GSH水平和GSH相关酶活性降低了90%，提示β细胞具有较低的氧化还原活性和氧化应激能力。GSH.3可下调胰岛素的分泌。胰岛素原的表达不受GSH.4的调节。GSH对细胞因子诱导的胰岛β细胞损伤有保护作用。反义γ-GCS-核酶的表达增加了胰岛素的分泌。这些数据表明，β细胞中低浓度的GSH对胰岛素的分泌是必不可少的，但对氧化剂对细胞的损伤很敏感。综上所述，针对抑制GSH合成的新基因疗法被认为对IDDM有效。

项目成果

Iwanaga, M., et al: "Nuclear factor-kappa B dependent induction of gamma glutamylcysteine synthetase by ionizing in T98G human glioblastoma cells." Free Radical Biol.Med.(in press.).

Iwanaga, M. 等人：“通过在 T98G 人胶质母细胞瘤细胞中电离，依赖核因子 kappa B 诱导 γ 谷氨酰半胱氨酸合成酶。”

Ishibashi,M.,et al.: "Oxygen-inducedembryopathy and the significance of glutathione-dipendent antioxidant system in the rat embryo during early organogenesis." Free Radical Biol. Med.22. 1-8 (1996)

Ishibashi,M.,et al.：“氧诱导的胚胎病以及大鼠胚胎早期器官发生过程中谷胱甘肽依赖的抗氧化系统的重要性。”

Iwanaga M.,et al.: "Nuclear factor-kappa B dependent induction of gamma glutamylcysteine synthetase by ionizing radiation in T98G human glioblastoma cells." Free Radical Biol.Med.(in press).

Iwanaga M. 等人：“T98G 人胶质母细胞瘤细胞中电离辐射对核因子 kappa B 依赖性诱导的 γ 谷氨酰半胱氨酸合成酶。”

Urata,Y., et al.: "Long exposure to high glucose concentration impairs the responsive expression of γglutamylcysteine synthetase by interleukin-1β and tumor necrosis factor-α in mouse endothelial cells." J.Biol.Chem.271. 15146-15152 (1996)

Urata, Y., 等人：“长期暴露于高浓度葡萄糖会损害小鼠内皮细胞中白细胞介素 1β 和肿瘤坏死因子 α 的 γ 谷氨酰半胱氨酸合成酶的反应性表达。”J.Biol.Chem.271。 -15152 (1996)

Goto,S., et al.: "Augment of transport for cisplatin-glutathione adduct in cisplatin-resistant cancer cells." Cancer Res.55. 4297-4301 (1995)

Goto,S. 等人：“增强顺铂-谷胱甘肽加合物在顺铂耐药癌细胞中的转运。”